Exagen (XGN)
(Delayed Data from NSDQ)
$3.03 USD
+0.08 (2.71%)
Updated Sep 11, 2024 04:00 PM ET
After-Market: $3.10 +0.07 (2.31%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Cash flow Statements
Fiscal Year End for Exagen Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -23.69 | -47.39 | -26.85 | -16.69 | -12.04 |
Depreciation/Amortization & Depletion | 2.32 | 7.22 | 1.23 | 0.82 | 1.28 |
Net Change from Assets/Liabilities | 0.32 | 1.67 | -0.06 | -1.34 | 0.17 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.58 | 6.35 | 5.42 | 3.12 | 0.87 |
Net Cash From Operating Activities | -14.46 | -32.14 | -20.27 | -14.08 | -9.71 |
Property & Equipment | -0.80 | -4.32 | -2.37 | -0.46 | -0.10 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | -0.05 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.80 | -4.32 | -2.42 | -0.46 | -0.10 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.31 | 0.45 | 69.66 | 0.17 | 50.45 |
Issuance (Repayment) of Debt | -10.70 | -0.67 | -0.53 | -0.25 | -0.14 |
Increase (Decrease) Short-Term Debt | -0.24 | -0.03 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -0.24 | -4.45 | -0.02 | 18.42 |
Net Cash from Financing Activities | -10.63 | -0.49 | 64.68 | -0.10 | 68.73 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -25.90 | -36.95 | 41.99 | -14.64 | 58.92 |
Cash at Beginning of Period | 62.59 | 99.54 | 57.55 | 72.18 | 13.26 |
Cash at End of Period | 36.69 | 62.59 | 99.54 | 57.55 | 72.18 |
Diluted Net EPS | -1.34 | -2.77 | -1.68 | -1.32 | -8.46 |
Fiscal Year End for Exagen Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -6.33 | -3.36 | -23.69 | -18.12 | -12.70 |
Depreciation/Amortization & Depletion | 0.97 | 0.50 | 2.32 | 1.78 | 1.14 |
Net Change from Assets/Liabilities | -7.90 | -7.05 | 0.32 | -10.55 | -11.13 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.79 | 0.87 | 6.58 | 4.07 | 2.79 |
Net Cash From Operating Activities | -11.47 | -9.04 | -14.46 | -22.81 | -19.90 |
Property & Equipment | -0.22 | -0.09 | -0.80 | -0.72 | -0.72 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.22 | -0.09 | -0.80 | -0.72 | -0.72 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.10 | 0.10 | 0.31 | 0.31 | 0.18 |
Issuance (Repayment) of Debt | -0.27 | -0.14 | -10.70 | -10.54 | -10.37 |
Increase (Decrease) Short-Term Debt | -0.16 | -0.07 | -0.24 | -0.18 | -0.11 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | -0.33 | -0.10 | -10.63 | -10.41 | -10.30 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -12.01 | -9.23 | -25.90 | -33.94 | -30.93 |
Cash at Beginning of Period | 36.69 | 36.69 | 62.59 | 62.59 | 62.59 |
Cash at End of Period | 24.68 | 27.47 | 36.69 | 28.65 | 31.67 |
Diluted Net EPS | -0.16 | -0.19 | -0.31 | -0.31 | -0.28 |